Shows / OnCall

OnCall
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want -…
Episodes
OnCallQ3 2026 GPO Legislative Townhall
In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include recent changes…
OnCallQ2 2026 GPO Legislative Townhall
In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the Inflation…
OnCallBest Practices for Bispecifics
In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American…
OnCallImplementing Bispecifics in a Clinical Practice
In this episode, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr…
OnCallOperationalizing Bispecifics in Practice
In this episode, sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American…
OnCallThe Basics of Bispecifics
In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American…
OnCallQ1 2026 GPO Legislative Townhall
In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the 2026…
OnCallOperationalizing Radiopharmaceuticals in Your Practice
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network…
OnCallRadiopharmaceuticals: Billing and Reimbursement
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network…
OnCallRadiopharmaceutical Landscape
In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network…
OnCallIntroduction to Radiopharmaceuticals
In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology…
OnCallQ4 2025 GPO Legislative Townhall
In this episode, Joel White, Partner and Head of Health at Monument Advocacy, talks about updates on DC legislative and regulatory issues, what to expect in…
OnCallQ3 GPO Legislative Townhall
In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and…
OnCallInflation Reduction Act: Current State
In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to…
OnCallQ2 GPO Legislative Townhall
In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms…
OnCallInflation Reduction Act: Overview
In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty…
OnCall505(b)(2) Operationalizing in Practice - Provider Perspective
In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network…
OnCall505(b)(2) Operationalizing in Practice - Pharmacist Perspective
In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at…
OnCall505(b)(2) Billing and Reimbursement
In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology…
OnCall505(b)(2) Landscape and Pipeline
In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology…
OnCall505(b)(2) Basics
In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for…
OnCallBuy and Bill: Practice Perspective
In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's…
OnCallBuy and Bill: The Basics
In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill. To find a…
OnCallGPO 101: Legislative Townhall
In this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug…
OnCallBiosimilar Basics: Payer Perspective
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective. If you have any questions for our guests or…
OnCallBiosimilar Basics: Legislation
In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of…
OnCallBiosimilar Basics: Market Landscape
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization…
OnCallBiosimilar Basics: Overview
In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization…
OnCallGPO Legislative Townhall December 2023: Part 11
In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and…
OnCallGPO Legislative Townhall December 2023: Part 10
In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the…
OnCallGPO Legislative Townhall December 2023: Part 9
In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around…
OnCallGPO Legislative Townhall August 2023: Part 8
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug…
OnCallGPO Legislative Townhall August 2023: Part 7
In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the…
OnCallGPO Legislative Townhall May 2023: Part 6
In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed…
OnCallGPO Legislative Townhall May 2023: Part 5
In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public…
OnCallGPO Legislative Townhall May 2023: Part 4
In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and…
OnCallGPO Legislative Townhall Feb 2023: Part 3
In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the…
OnCallGPO Legislative Townhall Feb 2023: Part 2
In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug…
OnCallGPO Legislative Townhall Feb 2023: Part 1
In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three…
OnCallOperational Pathways for Biomarker Testing in NSCLC
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on…
OnCallBiosimilar Series: Part 5
In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing…
OnCallBiosimilar Series: Part 4
In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the…
OnCallBiosimilar Series: Part 3
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval…
OnCallBiosimilar Series: Part 2
In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for…
OnCallBiosimilar Series: Part 1
In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for…
OnCallBiomarkers: Emerging Targets and Technologies
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to…
OnCallBiomarker Testing: A Closer Look at When, Who, and How to Test
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to…
OnCallGermline Genetic Testing
In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss…
OnCallBuy and Bill 101: Part 4
In the final episode of our buy and bill series, we discuss reducing financial barriers for your patients and talk to Joe Baffone, CEO of Annexus Health, about…
OnCallBuy and Bill 101: Part 3
In this episode, we talk about the reimbursement aspect of the buy and bill model and the four key issues that could negatively impact the health of your…
OnCallBiomarkers 101: Basics of Biomarker Testing
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to…
OnCallBuy and Bill 101: Part 2
In this episode, we discuss the benefits of buy and bill, how to get reimbursed, steps to take for timely payment and the important role patient assistance…
OnCallBuy and Bill 101: Part 1
This is the first episode in our series covering buy and bill. As more drugs that utilize this payment model enter the market, we want to make sure you have…
OnCallNovel Agents and Toxicity Management 101
The rise of genomic sequencing and use of novel agents in the new standard of cancer care has created new challenges in recognizing and managing toxicities. In…
OnCallUsing AI Clinical Decision Support to Manage Cancer Complexity
The average oncologist would need 29 hours a day to keep up with the advances in cancer care. There are new treatments, policies, drugs, toxicities, trials—and…
OnCallParadigms, Policy and Pharmacogenomics: What community oncologists need to know
The evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right…
OnCallClinical trials: How has precision medicine elevated the role of community oncology?
Precision medicine is refocusing which clinical trials are possible, but we still have a ~5% participation rate and non-diverse patient demographic. Community…
OnCallTreating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML
Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD. Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at…
OnCallOff Our Chests: A Discussion with Dr. John and Liza Marshall
In this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and…
OnCallPrecision Medicine Series: Evolution Part 2
In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for…